nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00164	0.00164	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR1A—Parkinson's disease	0.00164	0.00164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR1A—Parkinson's disease	0.00164	0.00164	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GRM4—Parkinson's disease	0.00163	0.00163	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GRM4—Parkinson's disease	0.00163	0.00163	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—TAC1—Parkinson's disease	0.00161	0.00161	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—TAC1—Parkinson's disease	0.00161	0.00161	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Ramelteon—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Ramelteon—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00156	0.00156	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PENK—Parkinson's disease	0.00154	0.00154	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PENK—Parkinson's disease	0.00154	0.00154	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAG—Parkinson's disease	0.00154	0.00154	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAG—Parkinson's disease	0.00154	0.00154	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD3—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD3—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—DRD2—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—DRD2—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—HTR7—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—HTR7—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Ramelteon—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00151	0.00151	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.0015	0.0015	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00145	0.00145	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PDYN—Parkinson's disease	0.00141	0.00141	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PDYN—Parkinson's disease	0.00141	0.00141	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD2—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR7—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD2—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR7—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GFAP—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GFAP—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00132	0.00133	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GRM5—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GRM5—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.00128	0.00128	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00128	0.00128	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—IL6—Parkinson's disease	0.00123	0.00123	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—IL6—Parkinson's disease	0.00123	0.00123	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.00122	0.00122	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—EDN1—Parkinson's disease	0.00122	0.00122	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00122	0.00122	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—FGF20—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—FGF20—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ADORA2A—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EDN1—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EDN1—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00105	0.00105	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—INSR—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—INSR—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000999	0.001	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000987	0.000987	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—FGB—Parkinson's disease	0.000973	0.000974	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—FGB—Parkinson's disease	0.000973	0.000974	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000971	0.000971	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000971	0.000971	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR1A—Parkinson's disease	0.000968	0.000969	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000968	0.000969	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000962	0.000963	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000957	0.000958	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TAC1—Parkinson's disease	0.000953	0.000954	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TAC1—Parkinson's disease	0.000953	0.000954	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000953	0.000954	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00094	0.000941	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD1—Parkinson's disease	0.000935	0.000935	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD1—Parkinson's disease	0.000935	0.000935	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD3—Parkinson's disease	0.000905	0.000906	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD3—Parkinson's disease	0.000905	0.000906	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.00088	0.00088	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000871	0.000872	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000865	0.000866	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00086	0.00086	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000853	0.000854	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000845	0.000846	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000845	0.000846	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR7—Parkinson's disease	0.000819	0.000819	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD2—Parkinson's disease	0.000819	0.000819	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD2—Parkinson's disease	0.000819	0.000819	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR7—Parkinson's disease	0.000819	0.000819	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000812	0.000812	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000797	0.000798	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000775	0.000776	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000771	0.000772	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000742	0.000743	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000732	0.000733	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000722	0.000723	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000719	0.000719	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000717	0.000718	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000712	0.000713	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000709	0.000709	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF2—Parkinson's disease	0.000686	0.000687	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF2—Parkinson's disease	0.000686	0.000687	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000679	0.00068	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00067	0.00067	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000663	0.000664	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF1R—Parkinson's disease	0.000663	0.000664	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.00066	0.000661	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EDN1—Parkinson's disease	0.000655	0.000656	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EDN1—Parkinson's disease	0.000655	0.000656	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000651	0.000652	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000621	0.000621	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NGF—Parkinson's disease	0.000602	0.000603	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NGF—Parkinson's disease	0.000602	0.000603	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR2A—Parkinson's disease	0.000573	0.000574	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR2A—Parkinson's disease	0.000573	0.000574	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000573	0.000573	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000565	0.000566	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000563	0.000563	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000563	0.000563	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000563	0.000563	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.00056	0.00056	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000559	0.000559	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.000555	0.000555	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000552	0.000553	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APOE—Parkinson's disease	0.000533	0.000533	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APOE—Parkinson's disease	0.000533	0.000533	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000524	0.000524	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000517	0.000517	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.000515	0.000515	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000508	0.000508	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000497	0.000498	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000468	0.000469	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000468	0.000469	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—INS—Parkinson's disease	0.000455	0.000456	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—INS—Parkinson's disease	0.000455	0.000456	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—OMD—Parkinson's disease	0.00044	0.000441	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.00044	0.000441	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000434	0.000435	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000432	0.000433	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000431	0.000432	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000428	0.000429	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000426	0.000427	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000417	0.000418	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000398	0.000398	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000397	0.000397	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000392	0.000392	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000388	0.000388	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000365	0.000365	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000365	0.000365	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000359	0.000359	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000355	0.000355	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000355	0.000355	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000355	0.000355	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000343	0.000343	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000343	0.000343	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CASP3—Parkinson's disease	0.000339	0.000339	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CASP3—Parkinson's disease	0.000339	0.000339	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6—Parkinson's disease	0.000337	0.000337	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6—Parkinson's disease	0.000337	0.000337	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000325	0.000325	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK8—Parkinson's disease	0.000312	0.000312	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK8—Parkinson's disease	0.000312	0.000312	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.00031	0.00031	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000282	0.000282	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000282	0.000282	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00028	0.00028	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000277	0.000277	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000277	0.000277	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000277	0.000277	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000265	0.000265	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000265	0.000265	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—DDC—Parkinson's disease	0.00026	0.000261	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000251	0.000251	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTA4—Parkinson's disease	0.000246	0.000246	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000243	0.000243	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000239	0.00024	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	0.000221	0.000222	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MAOB—Parkinson's disease	0.000219	0.000219	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000213	0.000214	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000213	0.000214	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000213	0.000214	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000209	0.000209	CbGpPWpGaD
Ramelteon—MTNR1A—forebrain—Parkinson's disease	0.000204	0.257	CbGeAlD
Ramelteon—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000203	0.000203	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—Parkinson's disease	0.000199	0.000199	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—Parkinson's disease	0.000199	0.000199	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000192	0.000192	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000189	0.000189	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000173	0.000173	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000171	0.000171	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	0.000163	0.000163	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000163	0.000163	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CTGF—Parkinson's disease	0.00016	0.00016	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000157	0.000157	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	0.000149	0.000149	CbGpPWpGaD
Ramelteon—MTNR1B—head—Parkinson's disease	0.000148	0.186	CbGeAlD
Ramelteon—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000148	0.000148	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NQO1—Parkinson's disease	0.000147	0.000147	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TH—Parkinson's disease	0.000145	0.000145	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYCS—Parkinson's disease	0.000139	0.00014	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000133	0.000133	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000132	0.000132	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000127	0.000127	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.000125	0.000125	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—COMT—Parkinson's disease	0.000123	0.000124	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTP1—Parkinson's disease	0.000123	0.000123	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MAOA—Parkinson's disease	0.000123	0.000123	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HMOX1—Parkinson's disease	0.000121	0.000121	CbGpPWpGaD
Ramelteon—MTNR1A—head—Parkinson's disease	0.000117	0.147	CbGeAlD
Ramelteon—CYP2C19—Metabolism—ABCB1—Parkinson's disease	0.000116	0.000116	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000116	0.000116	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.000115	0.000115	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TH—Parkinson's disease	0.000113	0.000113	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—Parkinson's disease	0.000113	0.000113	CbGpPWpGaD
Ramelteon—MTNR1A—nervous system—Parkinson's disease	0.000111	0.139	CbGeAlD
Ramelteon—CYP1A2—Metabolism—CYCS—Parkinson's disease	0.000109	0.000109	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPX1—Parkinson's disease	0.000108	0.000108	CbGpPWpGaD
Ramelteon—MTNR1A—central nervous system—Parkinson's disease	0.000107	0.134	CbGeAlD
Ramelteon—CYP2C19—Metabolism—MTHFR—Parkinson's disease	9.98e-05	9.99e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.8e-05	9.81e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—COMT—Parkinson's disease	9.62e-05	9.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.62e-05	9.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTP1—Parkinson's disease	9.58e-05	9.58e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MAOA—Parkinson's disease	9.55e-05	9.56e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HMOX1—Parkinson's disease	9.44e-05	9.45e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—APOE—Parkinson's disease	9.29e-05	9.3e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCB1—Parkinson's disease	9.07e-05	9.07e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.96e-05	8.97e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.86e-05	8.87e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—Parkinson's disease	8.8e-05	8.81e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TH—Parkinson's disease	8.73e-05	8.74e-05	CbGpPWpGaD
Ramelteon—MTNR1A—brain—Parkinson's disease	8.48e-05	0.106	CbGeAlD
Ramelteon—CYP1A2—Metabolism—GPX1—Parkinson's disease	8.43e-05	8.43e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.39e-05	8.39e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—INS—Parkinson's disease	7.94e-05	7.95e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTHFR—Parkinson's disease	7.78e-05	7.78e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—COMT—Parkinson's disease	7.43e-05	7.43e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.39e-05	7.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.37e-05	7.38e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.29e-05	7.3e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—APOE—Parkinson's disease	7.24e-05	7.25e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7e-05	7e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.79e-05	6.8e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.5e-05	6.51e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—INS—Parkinson's disease	6.19e-05	6.19e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6e-05	6.01e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APOE—Parkinson's disease	5.59e-05	5.59e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—INS—Parkinson's disease	4.77e-05	4.78e-05	CbGpPWpGaD
Ramelteon—CYP3A4—nervous system—Parkinson's disease	1.26e-05	0.0158	CbGeAlD
Ramelteon—CYP3A4—central nervous system—Parkinson's disease	1.21e-05	0.0152	CbGeAlD
